Articles by Daniel Marsh
BioCryst Shares Slide on HAE Drug Data, Focus Shifts to Cowen Conference
BioCryst Pharmaceuticals shares fell nearly 3% in premarket trading following new clinical data for its hereditary angioedema candidate navenibart. The company maintained its 2026 revenue outlook for ORLADEYO.
BioCryst Shares Slip on New Hereditary Angioedema Drug Data
BioCryst Pharmaceuticals shares fell premarket following new clinical data for its hereditary angioedema candidate navenibart. The company reaffirmed its 2026 revenue outlook and plans a Phase 3 filing by late 2027.
Vanguard S&P 500 ETF Slides on Iran Strike Fears, Oil Surge
Vanguard's S&P 500 ETF declined approximately 1% in Monday's premarket trading following military action against Iran, with oil prices jumping 8% and gold futures rising 3.4% as investors sought safety.
AT&T Shares Dip Amid Risk-Off Sentiment, Investors Eye Executive Commentary
AT&T shares edged lower in premarket activity Monday, tracking a broader market retreat fueled by geopolitical concerns and inflation jitters. Attention turns to executive commentary at upcoming telecom conferences.
AT&T Shares Dip Amid Broader Market Retreat, Focus Turns to Executive Commentary
AT&T shares declined 0.36% to $27.91 in premarket activity Monday as broader market futures fell over 1%. The telecom giant's executives are scheduled to speak at industry conferences this week, with investors seeking updates on subscriber trends and capital plans.
Netflix Exits Warner Bros. Discovery Talks Over Price, Paramount Deal in Focus
Netflix has withdrawn from acquisition discussions with Warner Bros. Discovery, with co-CEO Ted Sarandos stating a firm price ceiling of $27.75 per share. This development comes as Paramount Skydance's competing $31.00 all-cash offer undergoes regulatory review.
Apple Shares Dip Amid Geopolitical Tensions Ahead of Product Launch Week
Apple shares declined over 1% before the bell following a 3.2% drop Friday, pressured by broader market risk-off sentiment driven by Middle East tensions. The tech giant faces a pivotal week with product launches and a legal deadline.
AAPL Dips Amid Geopolitical Tensions Ahead of Key Product Launch Week
Apple shares declined over 1% before the bell, extending Friday's losses as rising oil prices and broader market jitters pressured tech. The selloff comes ahead of a pivotal week of product launches for the iPhone maker.
